Clinical trial
A Study With OPTIVATE® in People With Von Willebrand Disease
NCT00387192 · Bio Products Laboratory, Other · Terminated
Key facts
| NCT number | NCT00387192 |
|---|---|
| Title | A Study With OPTIVATE® in People With Von Willebrand Disease |
| Official title | An Open Multi-centre Study in Patients With Von Willebrand Disease to Investigate the Pharmacokinetics, Efficacy and Safety of OPTIVATE®, a High Purity, Dual Inactivated Factor VIII and Von Willebrand Factor Concentrate |
| Lead sponsor | Bio Products Laboratory, Other |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Von Willebrand Disease |
| Intervention type | Drug |
| Interventions | Optivate |
| Enrollment | 26 |
| Start date | Nov 1, 2006 |
| Completion | Sep 1, 2008 |
| First posted | Oct 12, 2006 |
| Last update posted | Mar 3, 2010 |
| Countries | Israel, United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: